Inovio Pharmaceuticals (NASDAQ:INO) Releases Quarterly Earnings Results, Misses Estimates By $0.18 EPS

Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) issued its earnings results on Tuesday. The biopharmaceutical company reported ($0.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by ($0.18), MarketWatch Earnings reports. The business had revenue of $0.84 million during the quarter, compared to the consensus estimate of $0.55 million. Inovio Pharmaceuticals […]

Related Keywords

United States ,Canada ,America , ,Morgan Stanley ,Geode Capital Management ,Zacks Investment Research ,Inovio Pharmaceuticals Inc ,Inovio Pharmaceuticals Company Profile Get Rating ,Earnings History For Inovio Pharmaceuticals ,Jefferies Financial Group ,Inovio Pharmaceuticals ,Royal Bank ,Get Rating ,Marketwatch Earnings ,Street Corp ,Capital Management ,Financial Group ,Investment Research ,Pharmaceuticals Company Profile ,Nasdaq Ino ,Ino ,Medical ,Earnings ,